eosine yellowish-(ys) has been researched along with transforming growth factor beta in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 8 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umehara, T | 1 |
| Hsu, MT; Lee, TC; Lin, CJ; Liu, TY; Shun, CT; Tyan, SW; Yang, PC; Yew, FH | 1 |
| Jung, HS; Oropeza, V; Thesleff, I | 1 |
| Higuchi, T; Ishikawa, I; Kinoshita, A; Oda, S; Takahashi, K | 1 |
| Funahashi, H; Hayakawa, Y; Hayashi, H; Hibi, Y; Imai, T; Itoh, T; Kikumori, T; Mase, T; Narita, T; Nishikawa, M; Shibata, A; Takahashi, M; Tanaka, Y; Tsukamura, K | 1 |
| Birrer, MJ; Farley, J; Gray, K; Jakowlew, SB; Nycum, L; Prentice, M | 1 |
| Beanes, SR; Chang, G; Dang, C; Freymiller, E; Hu, FY; Longaker, MT; Lorenz, HP; Nishimura, I; Soo, C; Ting, K; Wang, Y; Zhang, X | 1 |
| Ignotz, RA; Kojima, K; Kushibiki, T; Tabata, Y; Tinsley, KW; Vacanti, CA | 1 |
| Hattori, T; Inoda, H; Yamamoto, G | 1 |
| Grossniklaus, HE; Hamilton, SM; Kang, SJ; Kim, EK; Kim, TI; Lee, WB; Roh, MI; Schorderet, DF | 1 |
| Liang, Y; Tang, P; Wang, Y; Yao, Q; Zhang, L; Zhang, W | 1 |
| Bae, JH; Choi, KH; Kim, HJ; Kim, SE; Kim, SJ; Song, HR; Yang, JH; Yun, YP | 1 |
| Liu, LL; Wang, JH; Wang, L; Zhao, TJ; Zheng, Y | 1 |
| Han, X; Jiao, D; Lei, Q; Liu, Y; Xu, K | 1 |
| Dong, H; Huang, N; Jin, Z; Kang, J; Ning, B; Pan, L; Tian, L; Zhang, X; Zhang, Y | 1 |
| Cai, X; Dong, H; Guo, Y; Li, F; Lu, L; Luo, X; Qu, Y; Shen, B; Shen, Z; Xu, X; Zhang, Q; Zhou, C; Zhu, J | 1 |
| Duruksu, G; Ergen, SK; Rencber, SF; Subasi, S; Yazir, Y | 1 |
| Hao, X; Wei, H | 1 |
| Hua, LHK; Husain, SF; Khanna, S; Kok, L; Lam, WMR; Liau Zi Qiang, G; Liu Jiani, S; Liu, L; Weng, J; Wong, HK | 1 |
| Ji, H; Wang, X; Wang, Y; Xia, Z; Zhao, J | 1 |
20 other study(ies) available for eosine yellowish-(ys) and transforming growth factor beta
| Article | Year |
|---|---|
[Immunohistochemical localization of transforming growth factor-beta 1 in growth plate freshly transplanted into a full-thickness defect in articular cartilage].
Topics: Animals; Cartilage, Articular; Eosine Yellowish-(YS); Growth Plate; Hematoxylin; Immunohistochemistry; Male; Phenazines; Rats; Rats, Inbred Lew; Staining and Labeling; Transforming Growth Factor beta | 1994 |
Induction of pulmonary fibrosis in organ-cultured rat lung by cadmium chloride and transforming growth factor-beta1.
Topics: Animals; Azo Compounds; Cadmium Chloride; Carrageenan; Coloring Agents; Drug Synergism; Eosine Yellowish-(YS); Extracellular Matrix; Lung; Methyl Green; Organ Culture Techniques; Pulmonary Alveoli; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Tissue Fixation; Transforming Growth Factor beta | 1998 |
Shh, Bmp-2, Bmp-4 and Fgf-8 are associated with initiation and patterning of mouse tongue papillae.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Eosine Yellowish-(YS); Fibroblast Growth Factor 8; Fibroblast Growth Factors; Gene Expression Regulation, Developmental; Hedgehog Proteins; Hematoxylin; In Situ Hybridization; Mice; Mice, Inbred CBA; Mice, Inbred Strains; Proteins; Signal Transduction; Time Factors; Tongue; Trans-Activators; Transforming Growth Factor beta | 1999 |
Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Coloring Agents; Drug Carriers; Eosine Yellowish-(YS); Fluorescent Dyes; Gelatin; Hematoxylin; Humans; Lactic Acid; Male; Mandible; Mandibular Diseases; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Long-Evans; Recombinant Proteins; Transforming Growth Factor beta | 1999 |
Wakame seaweed suppresses the proliferation of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Body Weight; Bromodeoxyuridine; Cell Division; Endocrine Glands; Eosine Yellowish-(YS); Female; Hematoxylin; Immunohistochemistry; In Situ Nick-End Labeling; Iodine; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Phaeophyceae; Plant Extracts; Rats; Rats, Sprague-Dawley; Seaweed; Thyroid Gland; Thyroxine; Transforming Growth Factor beta | 1999 |
Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Topics: Activin Receptors, Type I; Adenocarcinoma; Carcinoma in Situ; Cell Cycle Proteins; Cell Transformation, Neoplastic; Cervix Uteri; Cyclin-Dependent Kinase Inhibitor p27; Eosine Yellowish-(YS); Female; Genes, Tumor Suppressor; Hematoxylin; Humans; Immunohistochemistry; Ligands; Microtubule-Associated Proteins; Neoplasm Staging; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Staining and Labeling; Transforming Growth Factor beta; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2000 |
Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization.
Topics: Animals; Collagen; Embryonic and Fetal Development; Eosine Yellowish-(YS); Female; Hematoxylin; Immunohistochemistry; Microscopy, Confocal; Prenatal Injuries; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin; Transforming Growth Factor beta; Wound Healing; Wounds, Penetrating | 2003 |
Tissue-engineered trachea from sheep marrow stromal cells with transforming growth factor beta2 released from biodegradable microspheres in a nude rat recipient.
Topics: Absorbable Implants; Animals; Biomarkers; Bone Marrow Cells; Cartilage; Collagen Type II; Coloring Agents; Eosine Yellowish-(YS); Equipment Design; Feasibility Studies; Gelatin; Hematoxylin; Microspheres; Models, Cardiovascular; Polyglycolic Acid; Rats; Rats, Nude; Sheep; Stromal Cells; Tissue Engineering; Trachea; Transforming Growth Factor beta | 2004 |
Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model.
Topics: Animals; Antimetabolites; Bone Diseases; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bromodeoxyuridine; Cell Proliferation; Collagen; Coloring Agents; Disease Models, Animal; Drug Carriers; Eosine Yellowish-(YS); Fluorescent Dyes; Hematoxylin; Humans; Male; Osteogenesis; Periosteum; Rats; Rats, Wistar; Recombinant Proteins; Skull; Time Factors; Transforming Growth Factor beta | 2004 |
Deposits of transforming growth factor-beta-induced protein in granular corneal dystrophy type II after LASIK.
Topics: Adult; Azo Compounds; Coloring Agents; Congo Red; Corneal Dystrophies, Hereditary; Corneal Stroma; Eosine Yellowish-(YS); Extracellular Matrix Proteins; Humans; Immunoenzyme Techniques; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Male; Methyl Green; Middle Aged; Staining and Labeling; Surgical Flaps; Transforming Growth Factor beta | 2008 |
A study of femoral neck fracture repair using a recombinant human bone morphogenetic protein-2 directional release system.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Screws; Dogs; Eosine Yellowish-(YS); Femoral Neck Fractures; Fracture Healing; Glycolates; Hematoxylin; Humans; Kinetics; Lactic Acid; Male; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiography; Radionuclide Imaging; Recombinant Proteins; Staining and Labeling; Transforming Growth Factor beta | 2009 |
The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Topics: Analysis of Variance; Animals; Bone Morphogenetic Protein 2; Bony Callus; Calcium Phosphates; Collagen Type I; Drug Delivery Systems; Durapatite; Eosine Yellowish-(YS); Escherichia coli; Femur; Hematoxylin; Humans; Male; Microscopy, Electron, Scanning; Osteogenesis; Osteogenesis, Distraction; Osteopontin; Osteotomy; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Staining and Labeling; Time Factors; Transforming Growth Factor beta; X-Ray Microtomography | 2012 |
Effect of Curcumol on NOD-Like Receptor Thermoprotein Domain 3 Inflammasomes in Liver Fibrosis of Mice.
Topics: Animals; Carbon Tetrachloride; Caspase 1; Collagen; Eosine Yellowish-(YS); Hematoxylin; Inflammasomes; Interleukin-1beta; Liver Cirrhosis; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Peanut Oil; RNA, Messenger; Saline Solution; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2022 |
Animal study of a newly designed metal airway brachytherapy stent loaded with radioactive
Topics: Animals; Brachytherapy; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Hyperplasia; Iodine Radioisotopes; Rabbits; Reactive Oxygen Species; Stents; Transforming Growth Factor beta | 2022 |
Apigenin inhibits fibrous scar formation after acute spinal cord injury through TGFβ/SMADs signaling pathway.
Topics: Actins; Animals; Apigenin; Cicatrix; Collagen; Eosine Yellowish-(YS); Fibronectins; Hematoxylin; Mice; Nerve Growth Factors; Recovery of Function; Signal Transduction; Spinal Cord; Spinal Cord Injuries; Transforming Growth Factor beta | 2022 |
Loss of YB-1 alleviates liver fibrosis by suppressing epithelial-mesenchymal transition in hepatic progenitor cells.
Topics: Animals; Cadherins; Choline; Collagen; Eosine Yellowish-(YS); Epithelial-Mesenchymal Transition; Ethionine; Hematoxylin; Liver Cirrhosis; Metalloproteases; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Stem Cells; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factors | 2022 |
Evaluation of clinical and histological effects of KGF-2 and NGF on corneal wound healing in an experimental alkali burn rabbit model.
Topics: Alkalies; Animals; Burns, Chemical; Corneal Injuries; Disease Models, Animal; Eosine Yellowish-(YS); Eye Burns; Fibroblast Growth Factor 10; Hematoxylin; Humans; Inflammation; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nerve Growth Factor; Rabbits; Transforming Growth Factor beta; Transforming Growth Factors; Wound Healing | 2022 |
LncRNA H19 alleviates sepsis-induced acute lung injury by regulating the miR-107/TGFBR3 axis.
Topics: Acute Lung Injury; Animals; bcl-2-Associated X Protein; Endothelial Cells; Eosine Yellowish-(YS); Hematoxylin; Interleukin-10; Interleukin-6; Lipopolysaccharides; Lung; Mice; MicroRNAs; Proteoglycans; Receptors, Transforming Growth Factor beta; RNA, Long Noncoding; Sepsis; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2022 |
Systemic Diclofenac Sodium Reduces Postoperative rhBMP-2 Induced Neuroinflammation: A Rodent Model Study.
Topics: Animals; Bone Morphogenetic Protein 2; Diclofenac; Eosine Yellowish-(YS); Hematoxylin; Humans; Lumbar Vertebrae; Matrix Metalloproteinase 12; Neuroinflammatory Diseases; Radiculopathy; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Rodentia; Seroma; Spinal Fusion; Transforming Growth Factor beta | 2023 |
Association of Nonpuerperal Mastitis with Cytokines Related to Helper T Cells TH1/TH2 and TH17/Treg.
Topics: Cytokines; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Interferon-gamma; Interleukin-10; Interleukin-17; Interleukin-2; Interleukin-4; Mastitis; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Transforming Growth Factor beta | 2023 |